Artificial intelligence (AI) has the potential to speed early stages of drug discovery. Yet harnessing its power requires optimizing how information from AI is transferred to researchers whose intuition is key to selecting drug candidates to move forward in a pipeline. Learn how software platforms for managing communications during drug discovery can be tools to create a pipeline centered on augmented intelligence, where AI enhances human decision making, rather than replaces it.
Copyright © 2024 American Chemical Society | 1155 Sixteenth Street NW | Washington, DC 20036 | View our Privacy Policy